BioSpace News Archive

Ponder & Co. (“Ponder”), a leading healthcare financial advisory firm, announced today the acquisition of Charleston, SC-based management consulting firm, Knowledge Capital Group (“KCG”), to add to the suite of services offered to healthcare organizations throughout the US.

Rapid Oxygen™ is proud to announce its partnership with the Connecticut Alliance of Boys & Girls Clubs. “Safety is priority #1 for Boys & Girls Clubs,” explains Don Maleto, Executive Director of the CT Alliance of Boys & Girls Clubs, further stating, “To be able to bring this level of safety with these devices into all of our clubs is incredible.

The U.S. Food and Drug Administration issued warning letters to two marketers and distributors of kratom products – Cali Botanicals of Folsom, California, and Kratom NC of Wilmington, North Carolina – for illegally selling unapproved, misbranded kratom-containing drug products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms.

Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced approval of a Clinical Use Patent for arfolitixorin in the United States.

Trait Biosciences Inc. (“Trait” or the “Company”), the largest integrated bio-technology innovator in the cannabis industry, today announced the US Patent and Trademarks Office (“USPTO”) has allowed it patent protection for breakthrough technology platforms that produce truly water-soluble cannabinoids and dramatically increase cannabinoid yields in hemp and cannabis.

CareSource, a nonprofit health plan, has named a new executive to its leadership team. Devon Valencia has been named Chief Information Officer.

Targeted Oncology™, a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, along with The American Journal of Managed Care® (AJMC®), announces the addition of CBCCA to their Strategic Alliance Partnership (SAP) programs.

Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally-defined consortia of human microbiome-derived bacteria, today announced that a Vedanta scientific team member, Silvia Caballero, Ph.D., has been named as one of MIT Technology Review’s Global Innovators Under 35.